Clene Deferred Long Term Liab from 2010 to 2024

CLNN Stock  USD 4.17  0.16  3.99%   
Clene Deferred Long Term Liabilities yearly trend continues to be very stable with very little volatility. Deferred Long Term Liabilities is likely to grow to about 21.9 M this year. Deferred Long Term Liabilities is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. View All Fundamentals
 
Deferred Long Term Liabilities  
First Reported
2010-12-31
Previous Quarter
20.8 M
Current Value
21.9 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Clene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clene's main balance sheet or income statement drivers, such as Interest Expense of 4.8 M, Tax Provision of 0.0 or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 45.2, Dividend Yield of 0.0 or PTB Ratio of 2.21. Clene financial statements analysis is a perfect complement when working with Clene Valuation or Volatility modules.
  
Check out the analysis of Clene Correlation against competitors.

Latest Clene's Deferred Long Term Liab Growth Pattern

Below is the plot of the Deferred Long Term Liab of Clene Inc over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Clene's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clene's overall financial position and show how it may be relating to other accounts over time.
Deferred Long Term Liab10 Years Trend
Slightly volatile
   Deferred Long Term Liab   
       Timeline  

Clene Deferred Long Term Liab Regression Statistics

Arithmetic Mean5,448,717
Geometric Mean823,886
Coefficient Of Variation164.27
Mean Deviation7,610,118
Median260,000
Standard Deviation8,950,554
Sample Variance80.1T
Range21.6M
R-Value0.78
Mean Square Error34.3T
R-Squared0.60
Significance0.0007
Slope1,553,787
Total Sum of Squares1121.6T

Clene Deferred Long Term Liab History

202421.9 M
202320.8 M
202118.1 M

About Clene Financial Statements

Clene investors utilize fundamental indicators, such as Deferred Long Term Liab, to predict how Clene Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Deferred Long Term Liabilities20.8 M21.9 M

Pair Trading with Clene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clene will appreciate offsetting losses from the drop in the long position's value.

Moving against Clene Stock

  0.51VCYT VeracytePairCorr
  0.49VERA Vera TherapeuticsPairCorr
  0.31VCEL Vericel Corp OrdPairCorr
The ability to find closely correlated positions to Clene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clene Inc to buy it.
The correlation of Clene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clene Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports:
Check out the analysis of Clene Correlation against competitors.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.614
Earnings Share
(5.29)
Revenue Per Share
0.069
Quarterly Revenue Growth
(0.66)
Return On Assets
(0.42)
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.